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Abstract The purpose of this investigation was the determi-
nation of the distribution of genotypes and alleles, residing
within interleukin 6 (IL6) and interleukin 1 (IL1) polymor-
phisms, among fetuses and neonates, congenitally infected
with Toxoplasma gondii, and among uninfected control cases.
The study included 22 fetuses and newborns infected with
T. gondii and 49 control cases. Screening for IgG and IgM
antibodies against the parasite and IgG avidity was performed
by enzyme-linked fluorescent assay (ELFA) tests. Quantita-
tion of T. gondii DNA in amniotic fluids was assayed by the
real-time Q PCR technique for the parasitic B1 gene. Geno-
types at IL6 and IL1 single nucleotide polymorphisms (SNPs)
were determined by a self-designed, nested polymerase chain
reaction-restriction fragment length polymorphism (PCR-
RFLP) assay. Representative genotypes at the studied loci
were confirmed by sequencing. All the genotypes were esti-
mated for Hardy–Weinberg equilibrium and IL1 genotypes
were tested for linkage disequilibrium. Genotypes and haplo-
types at the studied SNPs were investigated for their possible
association with the occurrence of congenital T. gondii infec-
tion, using a logistic regression model. GC heterozygotes at
the IL6 −174 G>C SNP were significantly associated with
toxoplasmosis and increased the risk of T. gondii infection
[odds ratio (OR) 4.24, 95 % confidence interval (CI) 1.24–
14.50 in the codominant model, p≤0.050]. In case of IL1
SNPs, similar prevalence rates were observed between
T. gondii-infected and -uninfected offspring. Regarding allelic
variability, the C alleles at both IL6 and IL1B SNPs were
significantly more frequent in the infected than in the unin-
fected cases (p≤0.050). It is concluded that IL6 −174 G>C
and IL1B +3954 C>T SNPs might be involved in the devel-
opment of congenital T. gondii infection.
Introduction
Toxoplasma gondii is one of the most common intrauterine
infections worldwide and the major cause of perinatal morbid-
ity and mortality [1–4]. Congenital infections with T. gondii
are diagnosed in about 0.07–2.9 % of live newborns, leading
to asymptomatic as well as symptomatic disease, sometimes
with fatal course [1, 5, 6].
Considering the immune response against T. gondii, several
studies have shown the role of proinflammatory cytokines,
including interleukin (IL) 6 and IL1 [7–9]. Among women
infected with T. gondii, IL6 expression was estimated to be
twice as high compared to the control cases [10]. In another
study, the development of toxoplasmosis-related ocular le-
sions among T. gondii-infected patients was reported to be
associated with high IL1 and TNF-α levels [11]. In turn, the
mice with more severe inflammation in the retina and vitreous
humor, related to ocular toxoplasmosis, had a reduced expres-
sion of ocular IL1A and an increased production of TNFA
mRNA as compared to WT mice [12]. In an in vitro study,
the human monocytic wild-type MonoMac6 cells, infected
with T. gondii, showed significantly higher levels of IL-1β
as compared to non-infected cells [13]. Considering a possible
participation of the genetic alterations, located at IL1 and IL6
molecule encoding genes, the −174 G>C single nucleotide
polymorphism (SNP) from the IL6 gene was reported to be
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correlated with toxoplasmic retinochoroiditis (TR) [14]. The
prevalence rates of genotypes and alleles at the IL6 −174 G>C
SNP differed significantly between the patients with TR and
the healthy blood donors with positive serology for T. gondii
infection and without retinal symptoms of the previous disease
[14]. In turn, another study reported no correlation of either
IL1A −889 C>Tor IL1BC>T SNPs with the occurrence of TR
[15]. However, distinct differences in the distribution of geno-
types and alleles at the IL1A SNP were observed between
patients with and without recurrent episodes of the disease
[15]. So far, no study has been performed to seek for a possible
involvement of IL1 and IL6 SNPs in the development of con-
genital infection with T. gondii.
In the reported study, we aimed to analyze and describe a
possible influence of the polymorphisms located at the IL1A,
IL1B, and IL6 genes on the occurrence of congenital T. gondii
infection in fetuses and neonates. The haplotype prevalence
rates were also estimated for IL1 SNPs. A multiple-SNP anal-
ysis was performed to estimate the assumed simultaneous in-
fluence of IL1 and IL6 SNPs on the occurrence of the disease.
Materials and methods
The study included 22 fetuses congenitally infected with
T. gondii and 49 uninfected control cases, fromwhich samples
were retrospectively (16 infected cases and 25 controls) as
well as prospectively (six infected cases and 24 controls) col-
lected. The fetal and neonatal specimens were obtained from
the offspring of pregnant women treated at the Department of
Fetal-Maternal Medicine and Gynecology at the Polish
Mother’s Memorial Hospital—Research Institute in Lodz, be-
tween the years 2000 and 2014. Clinical samples, selected for
genetic studies, consisted of fetal amniotic fluids, obtained via
amniocentesis from pregnant women, and/or cerebrospinal
fluids (six samples), as well as umbilical cord blood speci-
mens (two samples). The intrauterine infections with T. gondii
were determined from maternal serological features of the
recent infection and by the clinical picture, including flu-like
symptoms, as well as by fetal and neonatal ultrasoundmarkers
associated with toxoplasmosis. The congenital infections with
T. gondii were confirmed by the presence of parasitic DNA in
fetal and neonatal body fluids. The research was approved by
the Research Ethics Committee at the Polish Mother’s Memo-
rial Hospital—Research Institute. All the samples, previously
collected for diagnostic purposes, are anonymized in this re-
port. Informed consent forms were signed by all the enrolled
participants (pregnant women).
Serological tests
Blood specimens were collected from the pregnant women by
venipuncture on their first visit to the hospital. Serum samples
were obtained by centrifugation and then stored at 4 °C until
analysis. Serological tests were performed at the hospital’s
Department of Clinical Microbiology.
Screening for T. gondii IgG antibodies was performed with
the enzyme-linked fluorescent assay (ELFA) VIDAS TOXO
IgG II (bioMérieux). The IgM antibodies were detected with
the ELFA assay VIDAS TOXO IgM (bioMérieux). T. gondii
IgG avidity was assayed by an ELFA assay VIDAS TOXO
IgG AVIDITY (bioMérieux). The pregnant women were di-
agnosed as recently infected with T. gondii in case of serocon-
version during pregnancy or were suspected to be infected in
case of the infection-related serology including IgM seropos-
itivity and low IgG avidity index. Fresh intrauterine T. gondii
infections, possible in the studied pregnant women, were con-
firmed by real-time Q PCR assays for the parasitic B1 gene
fragments, performed on body fluid specimens of their
offspring.
DNA extraction
Fetal genomic DNAwas extracted from 5-mL amniotic fluid
volumes or 3-mL cerebrospinal fluid volumes, and neonatal
DNA was extracted from 200 μL of umbilical cord blood
specimens, using a High Pure PCR Template Preparation Kit
(Roche™, Mannheim, Germany). The obtained DNAwas di-
luted in 100 μL of elution buffer and stored at −20 °C until
further molecular analyses.
Detection and quantification of T. gondii loads
The amount of T. gondii DNA was quantified by a real-time
(RT) Q PCR assay for the detection of parasitic B1 gene frag-
ment of 83 bps in length. Forward and reverse primers and
TaqMan MGB probe sequences were as follows: 5′-
CAAGCAGCGTATTGTCGAGTAGAT- 3 ′ , 5 ′ -
GCGTCTCTTTCATTCCCACATTTT-3′, and 5′-6-FAM-
CAGAAAGGAACTGCATCCGTT-NFQ-3′, respectively
[16]. The reactions were prepared in final 25-μL volumes, as
described previously [17].
Determination of SNPs located within IL1 and IL6 genes
IL1A −889 C>T, IL1B +3954 C>T, and IL6 −174 G>C SNPs
were genotyped, using self-designed nested polymerase
chain reaction (PCR) assays. The used external and internal
primer sequences, amplicon lengths, and annealing temper-
atures are shown in Table 1. External primer sequences
were developed using the Vector NTI Suite 5.5 software,
while the internal primers were based on published data
[14, 18–21]. The amplifications were performed with a
HotStarTaq® Master Mix Kit (Qiagen, Hilden, Germany).
The PCR conditions were as follows: an initial activation
for 15 min at 95 °C and for 40 cycles of repeated
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denaturation at 94 °C for 30 s, annealing at temperatures
designed for the used primer pairs (see Table 1), for 1 min,
and extension at 72 °C for 2 min, and a final extension at
72 °C for 10 min. The nested PCR products were resolved
on 1 % agarose gels, stained with ethidium bromide, and
then digested overnight with NcoI, TaqI, and Hsp92II en-
donucleases, used to determine genotypes at IL1A −889
C>T, IL1B +3954 C>T, and IL6 −174 G>C SNPs, respec-
tively (see Table 2). The products of digestion reactions
were resolved on 2 % agarose gels. Genotypes were deter-
mined at the analyzed polymorphic sites by the length of
restriction fragments, as described previously ([14, 18–21];
see Table 2, Fig. 1). The randomly selected PCR products,
including the analyzed SNPs, were then verified by se-
quencing according to the Sanger method. In case of IL1A
and IL1B SNPs, the sequencing was performed for seven
and nine CC homozygotes, four and five CT heterozygotes,
as well as for three and one TT homozygotes, respectively.
Regarding the IL6 SNP, sequencing was done for five GG
homozygotes, five GC heterozygotes, and 12 CC homozy-
gotes. Examples of chromatograms with DNA sequences of
distinct genotypes at the studied polymorphisms are shown
in Figs. 2 and 3. The sequenced and referenced DNA re-
gions were compared using the BLASTN program for
alignment of two (or more) sequences. The chromatograms
were read out using the Sequence Scanner 1.0 and Chromas
Lite 2.1.1 softwares.
Statistical analysis
The prevalence rates of genotypes and alleles at the IL1 and
IL6 polymorphisms in the infected and uninfected fetuses and
neonates were estimated by means of descriptive statistics.
The analyzed groups of patients were studied for the Hardy–
Weinberg (H-W) equilibrium, the linkage disequilibrium
(LD), and haplotypes, using the SNPStats software (http://
bioinfo.iconcologia.net/en/SNPStats_web). The correlation
of the genotypes, alleles, or haplotypes at IL SNPs with the
development of congenital T. gondii infections was
determined by cross-tabulation, Pearson’s Chi-squared, as
well as by the logistic regression model. The analysis of
haplotypes at IL1 SNPs and the multiple-SNP analysis were
carried out by the expectation–maximization (EM) algorithm.
The study results were estimated as being statistically signif-
icant when the significance level was p≤0.050. The statistical
analysis was, in part, supported by the NCSS 97 software.
Table 1 Primer sequences, annealing temperatures, and amplicon lengths obtained in the nested polymerase chain reaction (PCR) assays for IL1A,
IL1B, and IL6 polymorphisms
Gene GenBank
accession no.




IL1A NC_000002 −889 C>T
(rs1800587)







IL1B NC_000002 +3954 C>T
(rs1143634)
External For: GTAATAGACCTGAAGCTGGAACC 52 383
Rev: CCATTTACCTTGTTGCTCCATA
Internal For: GTTGTCATCAGACTTTGACC 59 249
Rev: TTCAGTTCATATGGACCAGA
IL6 NC_000007 −174 G>C
(rs1800795)
External For: GAAGTAACTGCACGAAATTTGAG 52 543
Rev: GATAAATCTTTGTTGGAGGGTGA
Internal For: CAGAAGAACTCAGATGACTG 58 431
Rev: GTGGGGCTGATTGGAAACC
No. number; SNP single nucleotide polymorphism; bps base pairs
Table 2 Length of restriction fragments and genotypic profiles at IL1
and IL6 polymorphisms
IL SNP Restriction enzyme Profile (bps)
IL1A −889 C>T NcoI CC: 266, 43
CT: 309, 266, 43
TT: 309
IL1B +3954 C>T TaqI CC: 135, 114
CT: 249, 135, 114
TT: 249
IL6 −174 G>C Hsp92II GG: 229, 173, 29
GC: 229, 173, 122, 51, 29
CC: 229, 122, 51, 29
SNP single nucleotide polymorphism; bps base pairs
Eur J Clin Microbiol Infect Dis (2015) 34:2287–2294 2289




(PCR-RFLP) products for distinct
genotypes at IL1A −889 C>T
single nucleotide polymorphism
(SNP) (a), IL1B +3954 C>T SNP
(b), and IL6 −174 G>C SNP (c).
DNA fragments, obtained by the
restriction analyses with NcoI (a),
TaqI (b), and Hsp92II (c)
endonucleases, were resolved in
2 % agarose gels, stained with
ethidium bromide. The numbers
on the right indicate the size of
separated DNA fragments. M 50-
bp DNA marker; Ud undigested
PCR product; CC, CT, TT, GG,
GC, CC genotypes at the studied
IL polymorphisms
Fig. 2 DNA sequences, containing IL1A −889 C>T SNP (a, b, c) and IL1B +3954 C>T SNP (d, e, f). DNA forward strands were sequenced for all the
analyzed SNPs. CC, CT, TT genotypes at the described IL1 SNP
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Results
Hardy–Weinberg equilibrium, linkage disequilibrium
The genotypes at all the analyzed polymorphic sites preserved
the H-Wequilibrium in the fetuses and neonates infected with
T. gondii (p=0.081, p=0.430, and p=0.680, for IL1A −889
C>T, IL1B +3954 C>T, and IL6 −174 G>C SNPs, respective-
ly). Taking into account the control cases, the genotypes at
IL1B +3954 C>T were in H-W equilibrium (p=0.150), while
the variants at IL1A −889 C>T and IL6 −174 G>C were not
(p≤0.050). IL1A −889 C>T and IL1B +3954 C>T SNPs were
seen in LD between the infected and the control groups of
patients (p≤0.050).
Prevalence rates of the genotypes at IL1A, IL1B, and IL6
SNPs
In the offspring infected with T. gondii, the prevalence
rates of CC, CT, and TT genotypes at IL1A −889 C>T/
IL1B C>T SNPs were 63.6 % (14/22)/72.7 % (16/22),
22.7 % (5/22)/22.7 % (5/22), and 13.6 % (3/22)/4.5 %
(1/22), respectively (see Table 3). Among the control
cases, the prevalence rates of the analyzed variants were
51.0 % (25/49)/57.1 % (28/49), 26.5 % (13/49)/30.6 %
(15/49), and 22.4 % (11/49)/12.2 % (6/49), respectively.
Taking into account the IL6 −174 G>C SNP, GG, GC,
and CC genotypes were carried by 27.3 % (6/22),
45.5 % (10/22), and 27.3 % (6/22) of the infected off-
spring, respectively. In control cases, the prevalence
rates of GG, GC, and CC variants at the IL6 SNP were
57.1 % (28/49), 22.4 % (11/49), and 20.4 % (10/49),
respectively. Considering the IL6 SNP, the GC hetero-
zygotes were significantly associated with toxoplasmosis
and increased the risk of T. gondii infection [odds ratio
(OR) 4.24, 95 % confidence interval (CI) 1.24–14.50 in
the codominant model, and OR 3.56, 95 % CI 1.19–
10.64 for GC and CC genotypes in the dominant model;
p≤0.050; see Table 3]. Regarding the IL1A and IL1B
SNPs, the observed genotypes were distributed similarly
between the infected and uninfected offspring. Neither
the haplotype analysis performed for IL1 SNPs nor the
multiple-SNP analysis for all the analyzed polymor-
phisms showed any differences in the prevalence rates
of distinct variants between the studied groups.
Distribution of the alleles at IL1 and IL6 SNPs
Among the infected fetuses and neonates, the prevalence
rates of C and T alleles at IL1A/IL1B SNPs were 75.0 %
(33/44)/84.1 % (37/44) and 25.0 % (11/44)/15.9 % (7/44),
respectively (see Table 4). In case of the uninfected pa-
tients, the analyzed alleles were found in 64.3 % (63/98)/
72.4 % (71/98) and 35.7 % (35/98)/27.6 % (27/98) of the
offspring, respectively. Taking into account the IL6 SNP,
the G and C alleles were identified in 50 % (22/44) of the
infected cases for each allele. In the uninfected controls,
the prevalence rates of G and C alleles were 68.4 % (67/
98) and 31.6 % (31/98), respectively. A cross-tabulation
analysis showed that alleles at the IL1A polymorphic site
were similarly distributed between T. gondii-infected and
-uninfected fetuses and neonates (see Table 4). In case of
the IL1B SNP, the major C allele was significantly more
frequent among the infected than among the uninfected
Fig. 3 Chromatograms of DNA sequences, comprising IL6 −174 G>C SNP (a, b, c). DNA forward strands were sequenced for all the analyzed SNPs.
GG, GC, or CC genotypes at the described IL6 SNP
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offspring (χ2=7, p≤0.050; Fisher’s exact test). Consider-
ing the IL6 SNP, the minor C allele was significantly
more frequent among the infected versus the uninfected
cases (χ2=4, p≤0.050; Fisher’s exact test).
Table 3 Single-SNP analysis of the relationship between genotypes at the IL1 and IL6 polymorphisms and the occurrence of congenital Toxoplasma
gondii infection
Gene polymorphism Genetic model Genotype Genotype prevalence rates, n (%) OR (95 % CI) p-Valuea
Infected cases Controls
IL1A −889 C>T Codominant CC 14 (63.6 %) 25 (51.0 %) 1.00 0.560
CT 5 (22.7 %) 13 (26.5 %) 0.69 (0.20–2.33)
TT 3 (13.6 %) 11 (22.4 %) 0.49 (0.12–2.04)
Dominant CC 14 (63.6 %) 25 (51.0 %) 1.00 0.320
CT-TT 8 (36.4 %) 24 (49.0 %) 0.60 (0.21–1.67)
Recessive CC-CT 19 (86.4 %) 38 (77.5 %) 1.00 0.380
TT 3 (13.6 %) 11 (22.4 %) 0.55 (0.14–2.19)
Overdominant CC-TT 17 (77.3 %) 36 (73.5 %) 1.00 0.730
CT 5 (22.7 %) 13 (26.5 %) 0.81 (0.25–2.66)
IL1B +3954 C>T Codominant CC 16 (72.7 %) 28 (57.1 %) 1.00 0.370
CT 5 (22.7 %) 15 (30.6 %) 0.58 (0.18–1.91)
TT 1 (4.5 %) 6 (12.2 %) 0.29 (0.03–2.64)
Dominant CC 16 (72.7 %) 28 (57.1 %) 1.00 0.200
CT-TT 6 (27.3 %) 21 (42.9 %) 0.50 (0.17–1.50)
Recessive CC-CT 21 (95.5 %) 43 (87.8 %) 1.00 0.280
TT 1 (4.5 %) 6 (12.2 %) 0.34 (0.04–3.02)
Overdominant CC-TT 17 (77.3 %) 34 (69.4 %) 1.00 0.490
CT 5 (22.7 %) 15 (30.6 %) 0.67 (0.21–2.14)
IL6 −174 G>C Codominant GG 6 (27.3 %) 28 (57.1 %) 1.00 ≤0.050
GC 10 (45.5 %) 11 (22.4 %) 4.24 (1.24–14.50)
CC 6 (27.3 %) 10 (20.4 %) 2.80 (0.73–10.72)
Dominant GG 6 (27.3 %) 28 (57.1 %) 1.00 ≤0.050
GC-CC 16 (72.7 %) 21 (42.9 %) 3.56 (1.19–10.64)
Recessive GG-GC 16 (72.7 %) 39 (79.6 %) 1.00 0.530
CC 6 (27.3 %) 10 (20.4 %) 1.46 (0.46–4.70)
Overdominant GG-CC 12 (54.5 %) 38 (77.5 %) 1.00 0.054
GC 10 (45.5 %) 11 (22.4 %) 2.88 (0.98–8.43)
p≤0.050 is considered significant
n number of tested fetuses and newborns; OR odds ratio; CI confidence interval
a Logistic regression model
Table 4 Distribution of the alleles located at the IL1 and IL6 SNPs
Gene polymorphisms and alleles No. of carriers with IL alleles (%) p-Value
Infected cases Controls
IL1A −889 C>T C 33 (75.0) 63 (64.3) 0.207a
T 11 (25.0) 35 (35.7)
IL1B +3954 C>T C 37 (84.1) 71 (72.4) ≤0.050b
T 7 (15.9) 27 (27.6)
IL6 −174 G>C G 22 (50.0 %) 67 (68.4 %) ≤0.050b
C 22 (50.0 %) 31 (31.6 %)
p≤0.050 is considered significant
No. number
a Pearson’s Chi-squared test
b Fisher’s exact test
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Discussion
In our study, we found that infants and neonates with GC geno-
types at the IL6 −174 G>C SNP were at an approximately four
times higher risk of congenital infection with T. gondii as com-
pared to GG and CC homozygotes.Moreover, the minor C allele
at the studied locus was significantly more prevalent among the
infected than in the uninfected offspring. Regarding T. gondii
infections, only one previous study, performed for patients with
TR and control cases, reported the role of the IL6 −174 G>C
polymorphism for the occurrence of disease [14]. Similarly to
our results, the prevalence rates of distinct genotypes at the ana-
lyzed IL6 locus were significantly different between the study
groups of patients and control cases. In patients with TR, the GC
heterozygotic status at the SNP was estimated to be correlated to
occurrence of the disease as well [14]. The significantly higher
prevalence rate of the C allele versus the G allele observed in our
study among the T. gondii-infected offspring as compared to the
control cases was also estimated for TR patients [14]. Previously,
the IL6 −174 G>C polymorphism was determined as being as-
sociatedwith altered expression levels of the encoded cytokine as
well [22–24]. Studies on the role of the IL6 −174 G>C SNP in
RSV-infected macrophages showed GC heterozygotes and CC
homozygotes as high IL6 production genotypes, correlated with
the infection, while among RSV-infected patients, the CC geno-
type at the analyzed SNPwas associated with low IL6 levels [22,
23]. Taking into account the papers reporting increased IL6 levels
to be correlated with T. gondii infection in various patient groups,
it seems possible that the GC heterozygotic status at the IL6 −174
G>C SNP may alter the immune response against the parasite
through higher IL6 cytokine production. However, a detailed
description of IL6 molecular changes, possibly associated with
congenital toxoplasmosis development, would be a challenge. So
far, the C allele at the IL6 −174G>C SNP was reported to gen-
erate new binding sites for NF-1 and Smad4 transcription factors,
which are not observed in the presence of the G allele [25, 26]. In
addition, a variable AnTn tract, located at the nucleotides from
−392 up to −373within the IL6 gene promoter, was also reported
to affect the transcription of −174 G allele and −174 C allele-
related haplotypes [27].
According to genetic modifications localized in IL1 genes, we
found the major C allele at the IL1B +3954 C>T SNP to be
significantly more frequent among the fetuses and neonates with
congenital T. gondii infection than among the uninfected cases.
So far, several studies showed some involvement of the proin-
flammatory IL1β cytokine in an immune response after T. gondii
infection, although the results are ambiguous [8, 11, 28]. Taking
into account IL1 polymorphisms, a previous study in TR patients
showed, likewise to our outcomes, similar distributions of the
genotypes and, in addition, of the alleles at the analyzed IL1A
−889C>Tand IL1B+3954C>TSNPs in patientswith TR and in
control cases [15]. The outcomes obtained in our study may
suggest that the presence of mutated T allele at the analyzed
IL1B SNP plays a protective function against the development
of congenital toxoplasmosis. However, the mechanism of the
role of the IL1B 3954 C>T SNP should be investigated in a
detailed molecular study.
Considering our outcomes, as presented in this paper, the GC
heterozygotic status at the IL6 −174 G>C SNP, as well as the
presence of C alleles at both IL6 and IL1B +3954 C>T SNPs,
seems to have been involved in the occurrence of congenital
toxoplasmosis in the studied fetuses and neonates. So far, several
studies have shown some contribution of the encoded IL6 and
IL1β cytokines to immune responses against T. gondii, although
no such research has been performed for congenital toxoplasmo-
sis. In case of IL6, the GC heterozygotic status at the −174 G>C
SNP was determined to be correlated with TR development,
while no such relationship was observed for either the IL1A
−889 C>T or IL1B +3954 C>T SNPs. Based on our outcomes,
we suggest a possible contribution of GC heterozygotic status at
the IL6 −174 G>C SNP to the immune response efficacy against
congenital T. gondii infection via an increased synthesis of the
IL6 cytokine, whereas the T allele at the IL1B +3954 C>T SNP
might be protective against the infection. Although the character
of observed genetic changes is suggestive of their effective rela-
tionship with congenital toxoplasmosis, a detailed further mech-
anistic research should be undertaken to investigate the hypoth-
esis in detail. We also suggest that further studies on the role of
IL6 and IL1 SNPs, performed with larger groups of patients with
congenital toxoplasmosis, would be beneficial to verify our
results.
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